2 months Krystal Q3 Earnings and Sales Top Estimates, Vyjuvek Gains Traction Zacks
KRYS beat on both earnings and sales in the third quarter of 2024. Lead drug Vyjuvek’s launch in the United States shows strong uptake.
XKRYS beat on both earnings and sales in the third quarter of 2024. Lead drug Vyjuvek’s launch in the United States shows strong uptake.
XTheStockMarketNews.com is a financial news aggregator for traders and investors that proposes to you the latest breaking news headlines on global financial markets, economy and business. Live trading analysis, opinions and forecasts on current stock market, currencies (Forex), cryptocurrency, commodities futures, ETFs, funds, bonds, rates and more. Disclaimer: by using any material of this website, you acknowledge and agree that TheStockMarketNews.com is not responsible for the content, actions or any legal issues arising from third-party websites; materials of this website are not financial advice or call to actions. Trading and investing in financial instruments involve high risks including the risk of investment loss.